{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T02:08:48Z","timestamp":1648692528093},"reference-count":28,"publisher":"Japanese Society of Internal Medicine","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2012]]},"DOI":"10.2169\/internalmedicine.51.7461","type":"journal-article","created":{"date-parts":[[2012,9,15]],"date-time":"2012-09-15T01:02:16Z","timestamp":1347670936000},"page":"2573-2579","source":"Crossref","is-referenced-by-count":5,"title":["Premature Atherosclerosis in a Japanese Diabetic Patient with Atypical Familial Partial Lipodystrophy and Hypertriglyceridemia"],"prefix":"10.2169","volume":"51","author":[{"given":"Masanori","family":"Iwanishi","sequence":"first","affiliation":[{"name":"Diabetes and Endocrine Division, Kusatsu General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Ebihara","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Kusakabe","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Harada","sequence":"additional","affiliation":[{"name":"Diabetes and Endocrine Division, Kusatsu General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ito-Kobayashi","sequence":"additional","affiliation":[{"name":"Diabetes and Endocrine Division, Kusatsu General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Tsuji","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kusatsu General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiminori","family":"Hosoda","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuwa","family":"Nakao","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Semple RK, Krishna V, Chatterjee K, O'Rahilly S. PPARG and human metabolic disease. J Clin Invest 116: 581-589, 2006.","DOI":"10.1172\/JCI28003"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Agarwal AK, Garg A. Genetic disorders of adipose tissue development, differentiation and death. Annu Rev Genomics Hum Genet 7: 175-199, 2006.","DOI":"10.1146\/annurev.genom.7.080505.115715"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Agarwal AK, Garg A. Genetic basis of lipodystrophies and management of metabolic complications. Annu Rev Med 57: 297-311, 2006.","DOI":"10.1146\/annurev.med.57.022605.114424"},{"key":"4","unstructured":"4. Kim SK, Park SW, Hwang IJ, Lee YK, Cho YW. High fat stores in ectopic compartments in men with newly diagnosed type 2 diabetes: an anthropometric determinant of carotid atherosclerosis and insulin resistance. International Journal of Obesity 34: 105-110, 2010."},{"key":"5","unstructured":"5. Garg A. Lipodystrophies: Genetic and acquired body fat disorders. J Clin Endocrinol Metab 96: 3313-3325, 2011."},{"key":"6","unstructured":"6. Ebihara K, Kusakabe T, Masuzaki H, et al. Genes and phenotype analysis of congenital generalized lipodystrophy in Japanese: a novel homozygous nonsense mutation in seipin gene. J Clin Endocrinol Metab 89: 2360-2364, 2004."},{"key":"7","unstructured":"7. Dunnigan MG, Cochrane MA, Kelly A, Scott JW. Familial lipoatrophic diabetes with dominant transmission. Quarterly Journal of Medicine 169: 33-48, 1974."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Hegele RA. Premature atherosclerosis associated with monogenic insulin resistance. Criculation 103: 2225-2229, 2001.","DOI":"10.1161\/01.CIR.103.18.2225"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Garg A. Gender differences in the prevalence of metabolic complications in familial partial lipodystrophy (Dunnigan variety). J Clin Endocrinol Metab 85: 1776, 2000.","DOI":"10.1210\/jc.85.5.1776"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Pollak L. Mayamoya disease and moyamoya syndrome. N Engl J Med 260: 1226-1237, 2009.","DOI":"10.1056\/NEJMra0804622"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Savage DB, Tan GD, Acerini CL, et al. Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-G. Diabetes 52: 910-917, 2003.","DOI":"10.2337\/diabetes.52.4.910"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hegele RA, Cao H, Frankowski C, Mathews S, Leff T. PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy. Dabetes 51: 3586-3590, 2002.","DOI":"10.2337\/diabetes.51.12.3586"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Agarwal AK, Grag A. A novel heterozygous mutation in peroxisom proliferator-activates receptor-G gene in a patient with familial partial lipodystrophy. J Clin Endorinol Metab 87: 408-411, 2002.","DOI":"10.1210\/jc.87.1.408"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Haque WA, Shimomura I, Matsuzawa Y, Garg A. Serum adiponectin and leptin levels in patients in patients with lipodystrophies. J Clin Endocrinol Metab 87: 2395-2398, 2002.","DOI":"10.1210\/jc.87.5.2395"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Cook JR, Semple RK. Hypoadiponectinemia-cause or consequence of human insulin resistance? J Clin Endocrinol Metab 95: 1544-1554, 2010.","DOI":"10.1210\/jc.2009-2286"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20: 1595-1599, 2000.","DOI":"10.1161\/01.ATV.20.6.1595"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Iwanishi M, Ebihara K, Kusakabe T, et al. Clinical characteristics and efficacy of pioglitazone in a Japanese diabetic patient with an unusual type of familial partial lipodystrophy. Metabolism 58: 1681-1687, 2009.","DOI":"10.1016\/j.metabol.2009.04.043"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ginsberg HN, Zhang YL, Hernandea-Ono A. Regulation of plasma triglycerides in insulin resistance and diabetes. Archives of Medical Research 36: 232-240, 2005.","DOI":"10.1016\/j.arcmed.2005.01.005"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Adiel M, Taskinen MR, Boren J. Fatty liver, insulin resistance and dyslipidemia current diabetes reports. 8: 60-64, 2008.","DOI":"10.1007\/s11892-008-0011-4"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Simha V, Garg A. Inherited lipodystrophies and hypertriglyceridemia. Current Opinion in Lipodology 20: 300-308, 2009.","DOI":"10.1097\/MOL.0b013e32832d4a33"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Semple RK, Sleigh A, Murgatroyd PR, et al. Post receptor insulin resistance contributes to human dyslipidemia and hepatic steatosis. J Clin Invest 119: 315-322, 2009.","DOI":"10.1172\/JCI37432"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Arioglu EA, Duncan-Morin J, Sebring N, et al. Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes. Ann Intern Med 133: 263-274, 2000.","DOI":"10.7326\/0003-4819-133-4-200008150-00009"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Owen KR, Donohoe M, Ellard S, Hattersley AT. Response to treatment with rosiglitazone in familial partial lipodystrophy due to a mutation in the LMNA gene. Diabet Med 20: 823-827, 2003.","DOI":"10.1046\/j.1464-5491.2003.01034.x"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Sleilati GG, Leff T, Bonnett JW, Hegele R. Efficacy and safety of pioglitazone in treatment of a patient with an atypical lipodystrophy syndrome. Endocri Pract 13: 656-661, 2007.","DOI":"10.4158\/EP.13.6.656"},{"key":"25","unstructured":"25. Ludtke A, Heckt K, Geneschel J, et al. Long-term treatment experience in a subject with Dunnigan-type familial partial lipodystrophy: efficacy of rosiglitazone. Diabet Med 22: 1611-1613, 2005."},{"key":"26","unstructured":"26. Gaudillat CC, Bancel AB, Beressi JP. Long-term improvement of metabolic control with pioglitazone in a woman with diabetes mellitus related to Dunigan syndrome: A case report. Diabetes Metab 35: 151-154, 2009."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Majal KA, Cooper MB, Luc SG, Taskinen MR, Betteridge DJ. The effect of sensitization to insulin with pioglitazone on fasting and postprandial lipid metabolism, lipoprotein modification by lipases, and lipid transfer activites in type 2 diabetic patients. Diabetologia 49: 527-537, 2006.","DOI":"10.1007\/s00125-005-0092-4"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Ynag X, Smith U. Adipose tissue distribution and risk of metabolic disease: does thiazolidinedione-induced adipose tissue redistribution provide a clue to the answer? Diabetologia 50: 1127-1133, 2007.","DOI":"10.1007\/s00125-007-0640-1"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/51\/18\/51_51.7461\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T17:44:12Z","timestamp":1621446252000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/51\/18\/51_51.7461\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":28,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.51.7461","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}